XBiotech
XBIT
38 hedge funds and large institutions have $14.7M invested in XBiotech in 2015 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 6 reducing their positions, and 3 closing their positions.
167% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 6
133% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 3
29% more capital invested
Capital invested by funds: $11.4M → $14.7M (+$3.29M)
12% more funds holding
Funds holding: 34 → 38 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$4.83M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.44M |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$540K |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
+$457K |
| 5 |
ProShare Advisors
Bethesda,
Maryland
|
+$338K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FHC
Forest Hill Capital
Little Rock,
Arkansas
|
-$672K |
| 2 |
Goldman Sachs
New York
|
-$506K |
| 3 |
BFG
Beacon Financial Group
Dallas,
Texas
|
-$321K |
| 4 |
AA
ALPS Advisors
Denver,
Colorado
|
-$97.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$30K |
XBIT Hedge Fund Activity: Q4 2015 in Review
38 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q4 2015, worth a combined $14.7M — up 29% from $11.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new XBIT positions and 3 closed out — a net gain of 4 holders — while 16 added to existing stakes and 6 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $4.83M. The largest seller was Forest Hill Capital, exiting entirely with an estimated $672K sold.
- 38 institutional investors held XBiotech (XBIT) as of Q4 2015, up from 34 in Q3 2015.
- Funds reported $14.7M of XBiotech stock for Q4 2015, up 29% quarter-over-quarter.
- 7 funds opened new XBiotech positions in Q4 2015 and 3 closed out, a net change of +4 holders.
- The largest XBiotech buyer in Q4 2015 was BlackRock Fund Advisors, an estimated $4.83M added.
- The largest XBiotech seller in Q4 2015 was Forest Hill Capital, an estimated $672K sold.
Based on aggregated 13F filings for Q4 2015.